Statistical analysis plan for the multicenter, open, randomized controlled clinical trial to assess the efficacy and safety of intravenous tirofiban vs aspirin in acute ischemic stroke due to tandem lesion, undergoing recanalization therapy by endovascular treatment (ATILA trial).
Elena Zapata-ArriazaManuel Medina-RodríguezFrancisco Moniche ÁlvarezAsier de Albóniga-ChindurzaMarta Aguilar-PérezLeire Ainz-GómezPablo Baena-PalominoAynara ZamoraBlanca Pardo-GalianaFernando Delgado-AcostaRoberto Valverde MoyanoElvira Jiménez-GómezIsabel Bravo ReyRafael Oteros FernándezIrene Escudero-MartínezIsabel Vielba-GomezLluis Morales CabaJose Díaz PérezEstefania García MolinaSonia MosteiroMaría Del Mar Castellanos RodrigoLaura Amaya PascasioCarlos HidalgoMaría Del Mar Freijo GuerreroEva González DíazJose María Ramírez MorenoLuis Fernández PrudencioMikel Terceño IzagaSaima Bashir ViturroMiguel Ángel Gamero-GarcíaSilvia Jiménez JorgeClara Rosso FernándezJoan MontanerAlejandro González GarcíaPublished in: Trials (2024)
The trial is registered as NCT05225961. February, 7th, 2022.
Keyphrases
- endovascular treatment
- phase iii
- study protocol
- phase ii
- clinical trial
- low dose
- minimally invasive
- randomized controlled trial
- cardiovascular events
- double blind
- type diabetes
- middle cerebral artery
- mesenchymal stem cells
- bone marrow
- percutaneous coronary intervention
- cell therapy
- atrial fibrillation
- placebo controlled